Management of Non-Transfusion-Dependent Thalassemia: A Practical Guide Ali T. TaherMaria Domenica Cappellini Therapy in Practice 26 September 2014 Pages: 1719 - 1729
Systemic Glucocorticoid Therapy: a Review of its Metabolic and Cardiovascular Adverse Events Laurence FardetBruno Fève Review Article 10 September 2014 Pages: 1731 - 1745
Antiepileptic Drugs for the Treatment of Agitation and Aggression in Dementia: Do They Have a Place in Therapy? Damien GallagherNathan Herrmann Review Article 20 September 2014 Pages: 1747 - 1755
Albumin-Bound Paclitaxel: A Review of Its Use for the First-Line Combination Treatment of Metastatic Pancreatic Cancer Sheridan M. Hoy Adis Drug Evaluation 27 September 2014 Pages: 1757 - 1768
Empagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus Lesley J. Scott Adis Drug Evaluation 02 October 2014 Pages: 1769 - 1784
Dabigatran Etexilate: A Review of Its Use in the Treatment of Acute Venous Thromboembolism and Prevention of Venous Thromboembolism Recurrence Sarah L. GreigKate McKeage Adis Drug Evaluation 01 October 2014 Pages: 1785 - 1800
Tiotropium Respimat® Soft Mist™ Inhaler: A Review of Its Use in Chronic Obstructive Pulmonary Disease Gillian M. Keating Adis Drug Evaluation 10 October 2014 Pages: 1801 - 1816
Suvorexant: First Global Approval Lily P. H. Yang R&D Insight Report 17 September 2014 Pages: 1817 - 1822
Oritavancin: First Global Approval Anthony Markham R&D Insight Report 20 September 2014 Pages: 1823 - 1828
Eliglustat: First Global Approval Raewyn M. Poole R&D Insight Report 20 September 2014 Pages: 1829 - 1836
Erratum to: Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications Toby TrujilloPaul P. Dobesh Erratum 09 October 2014 Pages: 1837 - 1837
Erratum to: Idelalisib: First Global Approval Anthony Markham Erratum 07 October 2014 Pages: 1839 - 1839
